Literature DB >> 15372223

Concerns of family members of patients receiving palliative sedation therapy.

Tatsuya Morita1, Masayuki Ikenaga, Isamu Adachi, Itaru Narabayashi, Yoshiyuki Kizawa, Yoshifumi Honke, Hiroyuki Kohara, Taketo Mukaiyama, Tatsuo Akechi, Yukie Kurihara, Yosuke Uchitomi.   

Abstract

PURPOSE: Symptomatic sedation is often required in terminally ill cancer patients and could cause significant distress to their families. The aim of this study was to gather vivid family descriptions about their experiences in palliative sedation therapy.
METHODS: This report is an additional analysis of a multicenter questionnaire survey. We performed content analysis on 48 statements described by 185 bereaved family members of patients who received palliative sedation therapy.
RESULTS: Family members reported guilt, helplessness, and physical and emotional exhaustion when patients received palliative sedation therapy. They were concerned about whether sedated patients experienced distress, wished to know that the maximum efforts had been made, wished to prepare for patient death, wished to tell important things to patients before sedation, wished to understand patients' suffering, and wanted medical professionals to treat patients with dignity.
CONCLUSIONS: To alleviate family distress, clinicians should understand families' emotional distress, ensure that unconscious patients feel no distress, reassure family members that the symptoms are truly refractory despite maximum efforts for symptom relief, give information and coordinate the situation to enable families to prepare for patient death and to tell important things to patients before sedation, help families to share patients' suffering, and treat patients the same as when they remained conscious.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372223     DOI: 10.1007/s00520-004-0678-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  11 in total

1.  The decision-making process in sedation for symptom control in Japan.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  Palliat Med       Date:  1999-05       Impact factor: 4.762

Review 2.  Responding to intractable terminal suffering: the role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine.

Authors:  T E Quill; I R Byock
Journal:  Ann Intern Med       Date:  2000-03-07       Impact factor: 25.391

3.  Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care.

Authors:  Mike Bennett; Viv Lucas; Mary Brennan; Andrew Hughes; Valerie O'Donnell; Bee Wee
Journal:  Palliat Med       Date:  2002-09       Impact factor: 4.762

4.  Family-peceived distress about appetite loss and bronchial secretion in the terminal phase.

Authors:  Tatsuya Morita; Kei Hirai; Yukihiro Sakaguchi; Satoru Tsuneto; Yasuo Shima
Journal:  J Pain Symptom Manage       Date:  2004-02       Impact factor: 3.612

5.  The ethical validity and clinical experience of palliative sedation.

Authors:  P Rousseau
Journal:  Mayo Clin Proc       Date:  2000-10       Impact factor: 7.616

6.  Factors considered important at the end of life by patients, family, physicians, and other care providers.

Authors:  K E Steinhauser; N A Christakis; E C Clipp; M McNeilly; L McIntyre; J A Tulsky
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

7.  The frequency and clinical course of cognitive impairment in patients with terminal cancer.

Authors:  J Pereira; J Hanson; E Bruera
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

8.  Family experience with palliative sedation therapy for terminally ill cancer patients.

Authors:  Tatsuya Morita; Masayuki Ikenaga; Isamu Adachi; Itaru Narabayashi; Yoshiyuki Kizawa; Yoshifumi Honke; Hiroyuki Kohara; Taketo Mukaiyama; Tatsuo Akechi; Yosuke Uchitomi
Journal:  J Pain Symptom Manage       Date:  2004-12       Impact factor: 3.612

Review 9.  Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria.

Authors:  Tatsuya Morita; Satoru Tsuneto; Yasuo Shima
Journal:  J Pain Symptom Manage       Date:  2002-10       Impact factor: 3.612

10.  Quality end-of-life care: patients' perspectives.

Authors:  P A Singer; D K Martin; M Kelner
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272

View more
  9 in total

Review 1.  [Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].

Authors:  B Alt-Epping; T Sitte; F Nauck; L Radbruch
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

2.  [Symptom control and ethics in final stages of COPD].

Authors:  Bernadette Hörfarter; Dietmar Weixler
Journal:  Wien Med Wochenschr       Date:  2006-05

3.  Considerations about hastening death among parents of children who die of cancer.

Authors:  Veronica Dussel; Steven Joffe; Joanne M Hilden; Jan Watterson-Schaeffer; Jane C Weeks; Joanne Wolfe
Journal:  Arch Pediatr Adolesc Med       Date:  2010-03

Review 4.  A cross-cultural comparison of hospice development in Japan, South Korea, and Taiwan.

Authors:  Anne P Glass; Li-Kuang Chen; Eunju Hwang; Yuzuho Ono; Lusine Nahapetyan
Journal:  J Cross Cult Gerontol       Date:  2010-03

5.  Family member satisfaction with end-of-life decision making in the ICU.

Authors:  Cynthia J Gries; J Randall Curtis; Richard J Wall; Ruth A Engelberg
Journal:  Chest       Date:  2008-01-15       Impact factor: 9.410

Review 6.  Palliative Sedation in End-of-Life Patients in Eastern Asia: A Narrative Review.

Authors:  Seung Hun Lee; Jung Hye Kwon; Young-Woong Won; Jung Hun Kang
Journal:  Cancer Res Treat       Date:  2022-04-19       Impact factor: 5.036

7.  No Negative Impact of Palliative Sedation on Relatives' Experience of the Dying Phase and Their Wellbeing after the Patient's Death: An Observational Study.

Authors:  S M Bruinsma; A van der Heide; M L van der Lee; Y Vergouwe; J A C Rietjens
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

8.  Dexmedetomidine for Sedation during Withdrawal of Support.

Authors:  Chris O'Hara; Robert F Tamburro; Gary D Ceneviva
Journal:  Palliat Care       Date:  2015-08-25

Review 9.  The Decision-Making Process for Palliative Sedation for Patients with Advanced Cancer-Analysis from a Systematic Review of Prospective Studies.

Authors:  Alazne Belar; Maria Arantzamendi; Johan Menten; Sheila Payne; Jeroen Hasselaar; Carlos Centeno
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.